Press release
Cerebral Thrombectomy Devices Market Growth, Trends, Absolute Opportunity and Value Chain 2018-2026
Cerebral Thrombectomy Devices Market: OverviewThrombectomy is the surgical removal of blood clots formed in blood vessels. The removal of blood clots from the blood vessels in the brain is known as cerebral thrombectomy and the devices used for the same are known as cerebral thrombectomy devices. Blockage in blood vessels in the brain can be caused due to various reasons such as atheroma, an embolus or a thrombus of one or more arteries. A blood clot may lead to the draining or leakage of blood into the brain, if left untreated. More than 90% of strokes account for cerebral infarction in the United States. According to the Centers for Disease Control and Prevention (CDC), around 130,000 Americans are killed by strokes every year. Cerebral infraction is an ischemic stroke that results in a lack of blood supply to the brain. The risk factors associated with cerebral infraction include diabetes, high blood pressure, tobacco smoking, hyperlipoproteinemia, atherosclerosis, obesity and hypercholesterolemia.
Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2703
Cerebral Thrombectomy Devices Market: Drivers and Restraints
The global increase in the incidences of chronic inflammatory diseases is expected to contribute significantly to the cerebral thrombectomy devices market growth. The growing incidences of cerebral infarction, due to the increasing prevalence of diabetes, obesity and other related factors are expected to drive the growth of the cerebral thrombectomy devices market. Sickle cell anemia is also associated with the rising incidences of blood clots in the blood vessels in the brain and thus, its growing prevalence directly contributes to the growth of the cerebral thrombectomy devices market.
The rising incidence rate of chronic kidney disease, which is one of the causative factors of cerebral venous thrombosis, is expected to fuel the cerebral thrombectomy devices market growth. Recent advancements in products in the cerebral thrombectomy devices market by manufacturers are expected to drive the growth of the market.
On the other hand, the high treatment cost associated with cerebral thrombectomy may hamper the growth potential of the cerebral thrombectomy devices market. Low awareness and availability of skilled professionals for cerebral thrombectomy may impede the cerebral thrombectomy devices market growth.
Cerebral Thrombectomy Devices Market: Overview
The rapidly increasing incidence rate of ischemic strokes is the major driver for the cerebral thrombectomy devices market. The global cerebral thrombectomy devices market, on the basis of product type, is expected to be dominated by the snare segment, owing to the higher adoption of these devices by healthcare professionals for cerebral thrombectomy. On the basis of end user, the cerebral thrombectomy devices market is expected to be dominated by the hospitals segment, due to the higher patient footfall for treatment. Manufacturers in the cerebral thrombectomy devices market are focusing on manufacturing advanced products for better patient compliance and to make the procedure easier.
Ask For Customized Report @ https://www.factmr.com/connectus/sample?flag=RC&rep_id=2703
Cerebral Thrombectomy Devices Market: Regional Outlook
The global cerebral thrombectomy devices market is expected to be dominated by North America, due to the higher adoption of these devices and the number of surgical procedures being performed using cerebral thrombectomy devices. Europe is expected to be the second most lucrative cerebral thrombectomy devices market, due to the higher incidences of cerebral venous thrombosis. Asia-Pacific is expected to be the fastest growing cerebral thrombectomy devices market due to rapidly improving healthcare infrastructure, coupled with the increasing penetration of cerebral thrombectomy devices and increasing availability of skilled professionals. The Latin America cerebral thrombectomy devices market is expected to witness steady growth, due to the improving product penetration in the region. The Middle East and Africa cerebral thrombectomy devices market is expected to be the least lucrative market, due to the low treatment seeking rate and comparatively less developed healthcare infrastructure in major regions.
Cerebral Thrombectomy Devices Market: Market Participants
Examples of some of the market participants in the global cerebral thrombectomy devices market include Penumbra, Inc., Stryker Corporation, Boston Scientific Corporation, ev3 Inc., Angiotech, Chestnut Medical Technologies, Inc., Abbott, Concentric Medical, Inc., NexGen Medical Systems, Cordis, Possis Medical, Inc., EKOS Corporation, Terumo Corporation, Medtronic plc and others.
For more information on this report, please visit:https://www.factmr.com/report/2703/cerebral-thrombectomy-devices-market
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/
Read Industrial News : http://insiderstribune.com/
Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/
Follow Us on Linkedin: www.linkedin.com/company/factmr/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cerebral Thrombectomy Devices Market Growth, Trends, Absolute Opportunity and Value Chain 2018-2026 here
News-ID: 1538147 • Views: …
More Releases from Fact.MR

Managed Security Services Market is Projected to Reach USD 93.72 Billion by 2034 …
The global managed security services (MSS) market is estimated at USD 27.85 billion in 2024 and is projected to increase at a remarkable CAGR of 12.9% to reach a value of USD 93.72 billion by the end of 2034. This expansion is driven by the escalating cyber threats, regulatory compliance requirements, and the growing complexity of IT environments. Managed security services provide outsourced monitoring and management of security devices and…

Magneto Resistive RAM Market is Estimated to Reach USD 7.25 Billion by 2034 | Ke …
Magneto Resistive RAM Market is estimated at USD 650.9 million in 2024 and is projected to grow at a CAGR of 27.3%, reaching USD 7.25 billion by 2034. This explosive expansion is driven by MRAM's superior attributes, including high-speed access, compact size, and resilience, making it ideal for edge computing, IoT devices, and applications requiring data durability. MRAM is increasingly replacing traditional flash and DRAM due to its scalability, density,…

Scalp Health Market is Forecasted to Reach USD 18.4 Billion by 2035 | Fact.MR Re …
Scalp Health Market is projected to reach USD 18.4 billion by 2035, rising from USD 9.6 billion in 2025, with a projected CAGR of 6.7% during the forecast period. This shift signifies a critical evolution in consumer behavior - one where the scalp is no longer viewed as a peripheral concern within haircare but as a standalone health domain intersecting dermatology, neurocosmetics, and preventative wellness. Driven by rising awareness of…

Basal Insulin Market is Projected to Reach USD 44,659 Million by 2035 | Key Play …
The global basal insulin market is expected to reach USD 44,659 million by 2035, up from USD 18,893 million in 2024. During the forecast period 2025 to 2035, the industry is projected to register at a CAGR of 8.3%, driven by the increasing burden of Type 2 diabetes, patient-friendly once-daily dosing, and advancements in long-acting analogs such as degludec and glargine. Enhanced delivery technologies, robust R&D, and expanding global diabetes…
More Releases for Cerebral
The Increasing Prevalence Of Cerebral Palsy : Core Growth Enabler in the Cerebra …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Cerebral Palsy Treatment Industry Market Size Be by 2025?
In the past few years, the market size of cerebral palsy treatment has seen consistent growth. It is expected to increase from $3.51 billion in 2024 to $3.66 billion in 2025, demonstrating a compound annual growth rate…
Cerebral Palsy Market - Unleashing Potential: Breakthrough Therapies Shaping the …
Newark, New Castle, USA: The "Cerebral Palsy Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cerebral Palsy Market: https://www.growthplusreports.com/report/cerebral-palsy-market/7988
This latest report researches the industry structure, sales, revenue,…
Cerebral Palsy Market - Driving Breakthroughs in Cerebral Palsy Care: Redefining …
Newark, New Castle, USA - new report, titled Cerebral Palsy Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Cerebral Palsy market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Cerebral Palsy market. The report offers an overview of the market, which…
Cerebral Palsy Therapeutics Clinical Trials & Results
In cerebral palsy, the term cerebral refers to brain and palsy refers to the loss or impairment of motor function. Cerebral palsy is a group of neurological disorders that appear in infancy or early childhood, and permanently affect body movement and muscle coordination.
Download the sample report @ https://www.pharmaproff.com/request-sample/1093
It is caused by damage or abnormalities inside the developing brain that disrupt its ability to control movement and maintain posture and balance.…
Rising Prevalence of Cerebral Malaria and Increasing Novel Drug Treatment Drives …
Malaria is a mosquito-borne infectious disease affecting humans and animals caused by parasitic protozoan belonging to the plasmodium family. Malaria is typically transmitted from human to human through the bite of an infected Anopheles (female) mosquito. Symptoms of malaria include fever, headache, fatigue, muscle pain, diarrhea, anemia, and vomiting. Severe malaria can cause yellow skin, seizures, coma, or death. Cerebral malaria is a form of severe malaria. Cerebral malaria has…
Cerebral Palsy - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Cerebral Palsy - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cerebral Palsy - Pipeline Review, H1 2017, provides an overview of the Cerebral Palsy (Central Nervous System) pipeline landscape.
Cerebral palsy is a group of disorders that can involve brain and nervous system functions, such as…